Pharmac

The New Zealand AIDS Foundation is welcoming a Pharmac decision to grant access to a preventive treatment for people at high risk of contracting HIV

The New Zealand AIDS Foundation is delighted at Pharmac’s decision to become one of the first countries in the world to publicly fund the HIV-prevention drug pre-exposure prophylaxis (PrEP)

The New Zealand AIDS Foundation applauds PHARMAC’s decision to become one of the first countries in the world to publicly fund the HIV-prevention drug Pre-Exposure Prophylaxis (PrEP) – meaning those at high risk of HIV have another way to protect themselves

People suffering from neck and head cancer, who can’t use chemotherapy, will soon have subsidised access to a new drug

Pharmac chief executive Steffan Crausaz is joining Auckland based primary healthcare provider Nirvana Health Group (NHG) in February as its chief operating officer

Campaigners pushed Pharmac to fund 12 months’ Herceptin for women with HER2-positive breast cancer. Now the data have arrived, and they do not suggest much advantage

A new treatment for hepatitis C that can be delivered by GPs took up more funding than any other medicine Pharmac funded in the year to 30 June 2017.